Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vaz

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
Natural Product Research|February 6, 2024
<i>In vitro</i> antitumor effects of aqueous extract and protease inhibitors from <i>Sterculia striata</i> st. Hil. et naud and metabolite profilingTadeu F Braga Junior, Nerilson M Lima, Gabriela P Carli, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 21, 2017
A new piperazine derivative: 1-(4-(3,5-di-tert-butyl-4-hydroxybenzyl) piperazin-1-yl)-2-methoxyethan-1-one with antioxidant and central activityAdriane F Brito, Patrícia C C S Braga, Lorrane K S Moreira, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 11, 2017
Pharmacological evaluation and molecular docking of new di-tert-butylphenol compound, LQFM-091, a new dual 5-LOX/COX inhibitorRoberta Campos Lino, Daiany Priscila Bueno da Silva, Iziara Ferreira Florentino, et al.
Acta Tropica|July 4, 2025
Metabolic disruptions in P. vivax malaria: Insights from four antimalarial treatment regimensMichael N Yakubu, Victor I Mwangi, Anne C G Almeida, et al.
Inflammopharmacology|September 4, 2023
Anti-inflammatory and antinociceptive effects, and safety toxicological profile of a new paracetamol analog, LQFM291Larissa Córdova Turones, Lucas S Machado, Boniek G Vaz, et al.
Scientific Reports|March 28, 2024
Host metabolomic responses in recurrent P. vivax malariaMichael N Yakubu, Victor I Mwangi, Rebeca L A Netto, et al.
Msystems|October 24, 2023
Methylprednisolone therapy induces differential metabolic trajectories in severe COVID-19 patientsVictor I Mwangi, Rebeca L A Netto, Mayla G S Borba, et al.
BMC Public Health|December 14, 2018
Towards an effective poliovirus laboratory containment strategy in NigeriaJohnson Muluh Ticha, Kolawole Olatunji Matthew, Abdullahi Walla Hamisu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 25, 2023
Preclinical data on morpholine (3,5-di-tertbutyl-4-hydroxyphenyl) methanone induced anxiolysisIara Barbosa Cabral, Caroline Vitória de Lima Moreira, Ana Carolina Cavalcante Rodrigues, et al.
European Journal of Cancer (Oxford, England : 1990)|August 25, 2023
Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 yearsJ Y Blay, S Piperno-Neumann, S Watson, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Natural Product Research|February 6, 2024
<i>In vitro</i> antitumor effects of aqueous extract and protease inhibitors from <i>Sterculia striata</i> st. Hil. et naud and metabolite profilingTadeu F Braga Junior, Nerilson M Lima, Gabriela P Carli, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 21, 2017
A new piperazine derivative: 1-(4-(3,5-di-tert-butyl-4-hydroxybenzyl) piperazin-1-yl)-2-methoxyethan-1-one with antioxidant and central activityAdriane F Brito, Patrícia C C S Braga, Lorrane K S Moreira, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 11, 2017
Pharmacological evaluation and molecular docking of new di-tert-butylphenol compound, LQFM-091, a new dual 5-LOX/COX inhibitorRoberta Campos Lino, Daiany Priscila Bueno da Silva, Iziara Ferreira Florentino, et al.
Acta Tropica|July 4, 2025
Metabolic disruptions in P. vivax malaria: Insights from four antimalarial treatment regimensMichael N Yakubu, Victor I Mwangi, Anne C G Almeida, et al.
Inflammopharmacology|September 4, 2023
Anti-inflammatory and antinociceptive effects, and safety toxicological profile of a new paracetamol analog, LQFM291Larissa Córdova Turones, Lucas S Machado, Boniek G Vaz, et al.
Scientific Reports|March 28, 2024
Host metabolomic responses in recurrent P. vivax malariaMichael N Yakubu, Victor I Mwangi, Rebeca L A Netto, et al.
Msystems|October 24, 2023
Methylprednisolone therapy induces differential metabolic trajectories in severe COVID-19 patientsVictor I Mwangi, Rebeca L A Netto, Mayla G S Borba, et al.
BMC Public Health|December 14, 2018
Towards an effective poliovirus laboratory containment strategy in NigeriaJohnson Muluh Ticha, Kolawole Olatunji Matthew, Abdullahi Walla Hamisu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 25, 2023
Preclinical data on morpholine (3,5-di-tertbutyl-4-hydroxyphenyl) methanone induced anxiolysisIara Barbosa Cabral, Caroline Vitória de Lima Moreira, Ana Carolina Cavalcante Rodrigues, et al.
European Journal of Cancer (Oxford, England : 1990)|August 25, 2023
Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 yearsJ Y Blay, S Piperno-Neumann, S Watson, et al.
Pageof 21